PTC Therapeutics, Inc.
PTCT
$50.46
-$0.11-0.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 231.21% | 202.70% | 42.02% | 29.38% | 22.41% |
| Total Depreciation and Amortization | -86.33% | -88.97% | -68.02% | -23.18% | 22.73% |
| Total Amortization of Deferred Charges | -17.43% | -30.62% | -36.04% | -44.88% | -25.62% |
| Total Other Non-Cash Items | -67.03% | -69.69% | -66.63% | -17.30% | -9.95% |
| Change in Net Operating Assets | 40.35% | -130.05% | 2,616.69% | -138.49% | -700.69% |
| Cash from Operations | 710.20% | 1,289.10% | 32.02% | 20.58% | 53.36% |
| Capital Expenditure | 48.15% | 104.91% | 77.14% | 73.64% | 53.68% |
| Sale of Property, Plant, and Equipment | -99.69% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.35% | 76.70% | 115.26% | -1,736.74% | -317.32% |
| Cash from Investing | -25.08% | 90.39% | 125.00% | -537.43% | -362.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 99.51% | -21,762.94% | -99.16% |
| Issuance of Common Stock | 271.55% | 80.08% | 12.57% | -69.98% | -67.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.12% | -76.33% | -75.64% | 2,289.77% | 2,328.15% |
| Cash from Financing | -97.45% | -58.82% | -60.42% | 158.45% | 369.53% |
| Foreign Exchange rate Adjustments | 392.38% | -98.95% | -335.32% | -26.81% | -71.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.91% | 181.32% | -41.14% | 488.48% | 783.66% |